EAAT1 Antibody [E21K7]

Catalog No.: F0777

Application: Reactivity: Human, Mouse, Rat

Immunofluorescent analysis of Hela cells using F0777 (green, 1:100), Hoechst (blue) and tubulin (Red).

サイズ（液体）	価格(税別)	在庫状況
20uL	JPY 25600	国内在庫なし(納期7~10日)
100uL	JPY 63200	国内在庫あり
100uL*2	JPY 94800	お問い合わせ

代表番号: 045-509-1970\|電子メール：sales@selleck.co.jp よく尋ねられる質問

使用情報

Dilution
IF1:100

Application
IF

Source
Rabbit Monoclonal Antibody

Reactivity
Human, Mouse, Rat

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃

Storage (from the date of receipt)
–20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
58 kDa

ポジティブコントロール	Rat brain; SW837
ネガティブコントロール	A549

プロトコール

IF
Experimental Protocol: Sample Preparation 1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use. 2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine. 3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time. 4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval. Fixation 1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes. 2. Wash the sample with PBS for 3 times, 3 minutes each time. Blocking Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.) Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background. Immunofluorescence Staining (Day 1) 1. Remove the blocking solution and add the diluted primary antibody. 2. Incubate the sample in a humidified chamber at 4°C overnight. Immunofluorescence Staining (Day 2) 1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time. 2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours. 3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time. 4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes. 5. Wash with PBST for 3 times, 5 minutes each time. Mounting 1. Mount the sample with an anti-fade mounting medium. 2. Allow the slide to dry at room temperature overnight in the dark. 3. Store the slide in a slide storage box at 4°C, protected from light.

Experimental Protocol:

Sample Preparation

1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.

2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.

3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.

4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.

Fixation

1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.

2. Wash the sample with PBS for 3 times, 3 minutes each time.

Blocking

Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)

Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.

Immunofluorescence Staining (Day 1)

1. Remove the blocking solution and add the diluted primary antibody.

2. Incubate the sample in a humidified chamber at 4°C overnight.

Immunofluorescence Staining (Day 2)

1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.

2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.

3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.

4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.

5. Wash with PBST for 3 times, 5 minutes each time.

Mounting

1. Mount the sample with an anti-fade mounting medium.

2. Allow the slide to dry at room temperature overnight in the dark.

3. Store the slide in a slide storage box at 4°C, protected from light.

Datasheet & SDS

生物学的記述

Specificity
EAAT1 Antibody [E21K7] recognizes endogenous levels of total EAAT1 protein.

タンパク質の局在
細胞膜

Uniprot ID
P43003

Clone
E21K7

Synonym(s)
EAAT1,GLAST-1/SLC1A3

Background
Glutamate serves as the primary excitatory neurotransmitter in the mammalian central nervous system, but prolonged activation of its system can lead to nerve damage and cell death. After release from the presynaptic neuron and synaptic transmission, glutamate is either reabsorbed into the presynaptic neuron or neighboring glial cells via transmembrane glutamate transporters. Among these, Excitatory Amino Acid Transporter (EAAT) 1 and EAAT2 are Na+-dependent transporters predominantly expressed in glial cells of the central nervous system. They play a crucial role in regulating glutamatergic excitability by preventing excess glutamate from spilling over beyond the synaptic cleft. This function is facilitated by their ability to bind and transport glutamate into astrocytes and microglia. The activity of EAAT1 and EAAT2 is tightly regulated at multiple levels, including gene expression, post-transcriptional splicing, glycosylation, and cell-surface trafficking. While EAAT2 is more abundant and well-studied in neurotransmission, EAAT1's specific role remains somewhat unclear. However, EAAT1 expression is known to increase in response to elevated glutamate concentrations in the media of cultured primary astrocytes, suggesting potential additional significance for this glutamate transporter. Notably, EAAT1 shows neuroprotective potential following ischemic events, as reactive astrocytes and activated microglia primarily express EAAT1 rather than EAAT2 during such conditions.

Background

Glutamate serves as the primary excitatory neurotransmitter in the mammalian central nervous system, but prolonged activation of its system can lead to nerve damage and cell death. After release from the presynaptic neuron and synaptic transmission, glutamate is either reabsorbed into the presynaptic neuron or neighboring glial cells via transmembrane glutamate transporters. Among these, Excitatory Amino Acid Transporter (EAAT) 1 and EAAT2 are Na+-dependent transporters predominantly expressed in glial cells of the central nervous system. They play a crucial role in regulating glutamatergic excitability by preventing excess glutamate from spilling over beyond the synaptic cleft. This function is facilitated by their ability to bind and transport glutamate into astrocytes and microglia. The activity of EAAT1 and EAAT2 is tightly regulated at multiple levels, including gene expression, post-transcriptional splicing, glycosylation, and cell-surface trafficking. While EAAT2 is more abundant and well-studied in neurotransmission, EAAT1's specific role remains somewhat unclear. However, EAAT1 expression is known to increase in response to elevated glutamate concentrations in the media of cultured primary astrocytes, suggesting potential additional significance for this glutamate transporter. Notably, EAAT1 shows neuroprotective potential following ischemic events, as reactive astrocytes and activated microglia primarily express EAAT1 rather than EAAT2 during such conditions.

References
[1] Parkin GM, et al. World J Psychiatry. 2018 Jun 28;8(2):51-63. [2] Beschorner R, et al. Histopathology. 2007 Jun;50(7):897-910.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%